Sign in  |  Register
Advanced search
Publication Cover

CITATION

Spence, David and Barnett, Henry JM. Stroke Prevention, Treatment, and Rehabilitation. McGraw-Hill Professional, 2012.

Stroke Prevention, Treatment, and Rehabilitation

Authors: David Spence and Henry JM Barnett

Published:  March 2012

eISBN: 9780071766760 0071766766 | ISBN: 9780071762359
Open eBook
  • Contents
  • Contributors
  • Preface
  • Section 1 Importance of Stroke and Stroke Prevention
  • Chapter 1 Epidemiology of Stroke Prevention and Urgency of Treatment
  • Introduction
  • Incidence and Prevalence
  • Burden of Stroke
  • Types of Stroke/Classification
  • Stroke Pathology
  • Stroke Prevention
  • Urgency of Treatment
  • Chapter 2 Potential for Stroke Prevention
  • Introduction
  • Rationale for Stroke Prevention, Traditional Approaches to Prevention, and Economic Considerations
  • Concept of Continuum of Risk and Global or Overall Risk
  • Difference in Risk When Traditional Risk Factors Are or Are Not Present
  • Ranking the Importance of Stroke Risk Factors: Population Attributable Risk
  • A Global Stroke Prevention Agenda
  • Future Stroke Prevention
  • Section 2 Preventing Stroke
  • Chapter 3 Nutrition, Diabetes, and Stroke Prevention
  • Introduction
  • Importance of Diet
  • Vitamins and Antioxidants
  • Conclusion
  • Chapter 4 Smoking Cessation
  • Smoking—Dogmas, Misconceptions, and Emerging Clinical Realities
  • Smoking and the Epidemiology of Cerebrovascular Disease
  • Smoking and the Pathophysiology of Cerebrovascular Disease
  • Secondhand Smoke and Cerebrovascular Disease
  • Cerebrovascular Events—Their Impact on the Smoker
  • Smoking Cessation and the Prevention of Stroke
  • The Cost-Effectiveness of Smoking Cessation
  • Smoking Cessation and the Stroke Patient
  • Enhancing Smoking Cessation Success
  • Pharmacotherapy for Smoking Cessation
  • Conclusion
  • Chapter 5 Exercise
  • Rationale
  • The Pre-exercise Evaluation
  • Exercise Programming
  • Chapter 6 Hypertension
  • Introduction
  • Achieving Control of Blood Pressure
  • Resistant Hypertension
  • Consumption of Substances That Aggravate Hypertension
  • Secondary Hypertension
  • Renovascular Hypertension
  • Primary Aldosteronism
  • Hypertension in Patients of African Origin
  • Physiologically Based Individualized Therapy Based on Renin/Aldosterone Phenotyping
  • Blockade of Aldosterone
  • Treating Hypertension in Acute Stroke
  • Chapter 7 Antiplatelet Therapy
  • Thienopyridines
  • Aspirin Plus Clopidogrel in Secondary Prevention of Stroke or TIA
  • Selection of Oral Antiplatelet Therapy
  • Chapter 8 Anticoagulation
  • Utilization of VKA Antagonists in Elderly Patients
  • Pharmacogenetic Dosing of Warfarin
  • Starting Anticoagulation After Stroke
  • Stopping Warfarin Before a Procedure
  • New Oral Anticoagulants
  • Chapter 9 Lipid-Lowering Therapy
  • Introduction
  • Reduction of Stroke Risk by Lipid-Lowering Therapy
  • Combination Therapy With Statins
  • Drug Interactions With Statins
  • Adverse Effects of Statins and How to Avoid Them
  • Conclusion
  • Chapter 10 Management and Prevention of Intracranial Atherosclerotic Disease
  • Introduction
  • Clinical Patterns of Intracranial Stenosis
  • Mechanisms, and Lesion and Angiographic patterns of ICAD
  • Risk Factor Management
  • Conclusion
  • Chapter 11 Appropriate Endarterectomy and Stenting for Carotid Stenosis
  • Introduction
  • Symptomatic Carotid Stenosis
  • Asymptomatic Carotid Stenosis
  • Conclusion
  • Chapter 12 Finding the Cause of the TIA or Stroke: The Key to Appropriate Therapy
  • Introduction
  • Stroke Mimics (“Just a Stroke”)
  • Stroke Subtypes
  • The Aorta as a Source of Embolic Ischemia Causing Stroke
  • Intracranial Hemorrhage
  • Hypertensive Intracerebral Hemorrhage
  • Subarachnoid Hemorrhage
  • Amyloid (Congophilic) Angiopathy
  • Cortical Vein Thrombosis
  • Vascular Malformations
  • Cerebral Ischemia
  • Arterial Dissection
  • Cardioembolic Stroke
  • Lacunar Infarction
  • Conclusion
  • Chapter 13 Thoughts on the Hazards of Relying on Publications: Cautions Needed Before Applying Published Results to Evidence-Based Medicine
  • Surgical Intervention in Symptomatic Patients With Carotid Stenosis
  • Surgical Intervention in Asymptomatic Subjects With Carotid Stenosis
  • Carotid Artery Stenting
  • Platelet-Inhibiting Drug Trials
  • Chapter 14 Prospects for Prevention of Dementia by Prevention of Stroke
  • Introduction
  • Definition of Key Terms and a Shift in Thinking About Cognitive Impairment
  • Magnitude of the Public Health Impact of Vascular Cognitive Impairment and Alzheimer Disease
  • Stroke and Cardiovascular Risk Factors and Linkage to Vascular Cognitive Impairment and Alzheimer Disease
  • Prevention of Dementia and Cognitive Decline: Practical and Research Considerations
  • Summary
  • Chapter 15 Minimizing Adverse Effects of Cardiovascular Drugs
  • Introduction
  • Antihypertensive Drugs
  • Adverse Effects by Drug Class
  • Blinded N of 1 Crossover Trial
  • Conclusion
  • Section 3 When the Stroke Wasn’t Prevented
  • Chapter 16 Treatment of Acute Stroke: Medical and Interventional Therapy
  • Introduction
  • Ischemic Stroke
  • Hemorrhagic Stroke
  • Organization of Stroke Care—What It Can Accomplish
  • Chapter 17 Surgical Management of Acute Stroke
  • Ischemic Stroke
  • Hemorrhagic Stroke
  • Chapter 18 Stroke Rehabilitation
  • Introduction
  • Brain Reorganization and Recovery From Stroke
  • Organized Stroke Care—Interdisciplinary Care/Team
  • Selected Rehabilitation Issues
  • Spasticity Poststroke
  • Visual-Spatial Perceptual Deficits
  • Vascular Cognitive Impairment
  • Aphasia
  • Dysphagia
  • Poststroke Depression (PSD)
  • Summary
  • Index